Detalles de la búsqueda
1.
ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with 89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol.
BMJ Open
; 12(11): e056708, 2022 11 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36400733
2.
PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study.
Int J Radiat Oncol Biol Phys
; 117(3): 675-682, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37406824
3.
Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survival.
Int J Radiat Oncol Biol Phys
; 99(4): 947-955, 2017 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29063854
Resultados
1 -
3
de 3
1
Próxima >
>>